BDFS Capital LLC Buys New Holdings in Cencora, Inc. $COR

BDFS Capital LLC purchased a new position in shares of Cencora, Inc. (NYSE:COR) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 2,461 shares of the company’s stock, valued at approximately $831,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Kemnay Advisory Services Inc. acquired a new stake in Cencora in the 4th quarter valued at $25,000. Oakworth Capital Inc. bought a new stake in Cencora during the 4th quarter valued at $26,000. Elyxium Wealth LLC acquired a new position in Cencora during the fourth quarter worth $27,000. Archer Investment Corp raised its holdings in Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora in the fourth quarter valued at $29,000. Institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Wells Fargo & Company reduced their price objective on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Morgan Stanley set a $342.00 target price on shares of Cencora in a report on Friday, May 8th. Citigroup dropped their price target on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. UBS Group lifted their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Finally, William Blair started coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $374.00.

Cencora Stock Performance

Shares of COR stock opened at $271.99 on Friday. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The firm has a 50-day moving average of $285.65 and a 200-day moving average of $324.72. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The company has a market cap of $52.92 billion, a P/E ratio of 20.86, a P/E/G ratio of 1.50 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the firm posted $4.42 earnings per share. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities research analysts forecast that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Friday, May 15th. Cencora’s payout ratio is presently 18.40%.

Cencora announced that its Board of Directors has approved a share buyback plan on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.